Juan Thomaz Gabriel, de Souza Ramos, Felipe Sanches, Ferrari, Morganna Freitas, Andrade, Caroline Souto, de Melo, Paulo José Fortes Villas, Boas, Nara Aline, Costa, Amanda Gomes, Pereira, Mariana Souza, Dorna, Paula Schmidt, Azevedo, Jay, Banerjee, Bethan E, Phillips, Philip J, Atherton, Bertha Furlan, Polegato, Katashi, Okoshi, Silmeia Garcia, Zanati, Sergio Alberto Rupp, Paiva, Leonardo Antonio Mamede, Zornoff, Marcos Ferreira, Minicucci, Universidade Estadual Paulista (UNESP), Complexo Hospitalar Santa Genoveva de Uberlândia, UFG- Univ Federal de Goiás, University of Leicester, and University of Nottingham
Made available in DSpace on 2022-04-29T08:37:25Z (GMT). No. of bitstreams: 0 Previous issue date: 2022-02-01 Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) Universidade Estadual Paulista Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) The objective of this study was to evaluate the association between frailty, evaluated by the Clinical Frailty Scale (CFS) and FRAIL scale, and C-terminal agrin fragment (CAF) levels with 3-month mortality following ST-segment elevation myocardial infarction (STEMI). This was a prospective observational study that included patients over the age of 18 years with STEMI admitted to the coronary intensive care unit. Within 48 h of admission, the CFS and FRAIL scale were applied and blood samples collected for serum CAF evaluation. Patients were followed for 3 months after hospital discharge, and mortality was recorded. One hundred and eleven patients were included; mean age was 62.3 ± 12.4 years, 61.3% were male and 11.7% died during the 3 months of follow-up. According to the CFS, 79.3% of the patients were classified as not frail, 12.6% as pre-frail and 8.1% as frail. According to the FRAIL scale, 31.5% of the patients were classified as not frail, 53.2% as pre-frail and 15.3% as frail. In univariate analysis, the CFS but not FRAIL scale was associated with mortality. In multiple logistic regression analysis, pre-frail/frail according to CFS (odds ratio [OR]: 6.118; CI 95%: 1.344–27.848; p = 0.019) and CAF levels (OR: 0.943; CI 95%: 0.896–0.992; p = 0.024) were associated with increased 3-month mortality. In a sub-analysis of 53 patients ≥65 years, CFS and CAF levels were associated with 3-month mortality. In conclusion, CAF levels and frailty determined by the CFS were associated with 3-month mortality after STEMI in the general and older population. Internal Medicine Department Botucatu Medical School Univ Estadual Paulista UNESP University Hospital Botucatu Medical School Sao Paulo State University UNESP Department of Anesthesiology Complexo Hospitalar Santa Genoveva de Uberlândia Faculty of Nutrition UFG- Univ Federal de Goiás Geriatric Emergency Medicine University Hospitals of Leicester School of Health Science University of Leicester Medical Research Council-Versus Arthritis Centre for Musculoskeletal Ageing Research and National Institute for Health Research (NIHR) Nottingham Biomedical Research Centre University of Nottingham Internal Medicine Department Botucatu Medical School Univ Estadual Paulista UNESP University Hospital Botucatu Medical School Sao Paulo State University UNESP CNPq: 304298/2019-0